Given the known benefits to BMZ for preterm infants and the difficulty in predicting which women will actually deliver preterm, it is common for providers to administer antenatal corticosteroids in an effort not to miss the opportunity to give them before delivery and to try and get the maximal time benefit. However, many of these babies will be born at term. Do these term born babies benefit or experience adverse outcomes after steroid exposure? In this session, we will review an article that is published ahead of print from the AJOG. The results may surprise you. (Reference: McKinzie, A., et al. Are Newborn Outcomes Different for Term Babies Who Were Exposed to Antenatal Corticosteroids? AJOG 2021)
Activity